Dr. Duffy advises on asset allocation strategy, economic analysis, and portfolio design. He was a founder and Senior Managing Director at the Strategic Investment Group (Strategic), an Arlington, Virginia-based manager of customized portfolios for institutional and private investors.   Dr. Duffy was also founder of Emerging Markets Management (now Ashmore, LLC) and, until its sale to Ashmore, PLC, was EMM’s Treasurer and Managing Director.  EMM, established in 1987, was one of the first investment management firms to specialize in the management of emerging market equities.  Strategic and EMM were founded in 1987 by members of the senior pension investment team and capital markets department of the World Bank group.   Prior to the founding of Strategic and EMM, he was a senior investment officer at the World Bank and an economist with the Board of Governors of the Federal Reserve Board in Washington, DC.  

Dr. Duffy is a former trustee and treasurer of the China Medical Board of New York, Inc., and the successor organization to the China Medical Board division of the Rockefeller Foundation, formed in 1914 to manage the Foundation’s developing interests in medicine and medical education in China.

Dr. Duffy earned a BA in economics from the University of Michigan in 1977 and both an MA and PhD in economics from the University of Chicago in 1979 and 1985, respectively.  He is a Chartered Financial Analyst and completed the Series 65 and 3 securities examinations.  He is a member the CFA Institute and the CFA Society of Washington, DC.  Dr. Duffy was a featured speaker at University of Virginia Darden School of Business Batten Institute’s Valuation in Emerging Markets Conference in May 2002.

Dr. Duffy is a resident of McLean, Virginia.  He is the father of four children and three grandchildren.

Dr. Duffy joined the board of trustees of the Carnegie Institution for Science in 2007 at the recommendation of David Swensen and was named a senior trustee in 2010.  He rejoined the board as a full trustee for a term beginning in July 2012 and currently chairs the Audit Committee and is a member of the Executive and Investment Committees.